SCHEMBL25823003

SCHEMBL25823003

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4cccc5cccc(-c6cc(-c7nc(-c8ccccc8)nc(-c8ccccc8)n7)cc(C7CCCCC7)c6)c45)cc(C4CCCCC4)c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
ADORA1 P30542 9/20 0.39
ADORA3 P0DMS8 6/20 0.39
ADORA2A P29274 5/20 0.39
CASP3 P42574 2/20 0.39
SENP7 Q9BQF6 2/20 0.39
SENP6 Q9GZR1 2/20 0.39
POLB P06746 1/20 0.39
S1PR1 P21453 2/20 0.38
S1PR5 Q9H228 1/20 0.38
KMO O15229 1/20 0.38
ADORA2B P29275 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
ATM Q13315 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PDE5A O76074 1/20 0.36
ACP1 P24666 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25823054 0.88 S1PR1 (0.44) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL25827474 0.87 TDP1 (0.35) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL25822998 0.86 L3MBTL1 (0.53) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL23959648 0.86 L3MBTL1 (0.53) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL23959647 0.86 L3MBTL1 (0.53) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL23959741 0.85 TDP1 (0.49) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL25823036 0.84 CASP3 (0.45) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL25823068 0.84 S1PR1 (0.47) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL23959651 0.83 TDP1 (0.50) L3MBTL1TDP1ADORA1ADORA3ADORA2A
SCHEMBL23928347 0.83 TDP1 (0.50) L3MBTL1TDP1ADORA1ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225202-A1 CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225202-A1 CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225202-A1 CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CRY2, PER2 L3MBTL1 1424/4885TDP1 3027/4885ADORA1 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.